Pieris Pharmaceuticals (PIRS) director Davis received 24,700 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Todd C Davis (director at Pieris Pharmaceuticals Inc., PIRS) reported that they received 24,700 Stock Option (right to buy) on Dec 13, 2024.
- Reporting person
- Davis Todd C
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 13, 2024 | Grant or award (A) | Stock Option (right to buy)On 24,700 Common Stock1 | +24,700 | - | - | 24,700 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 24,700 direct
Footnotes from the filing
- 1. The stock options will vest and become exercisable in 36 equal monthly installments through the third anniversary of the grant date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Davis report in this PIRS Form 4?
Todd C Davis (director at Pieris Pharmaceuticals Inc., PIRS) reported that they received 24,700 Stock Option (right to buy) on Dec 13, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for PIRS
Earlier insider filings at PIRS
- Dec 18, 2024SEC Form 4 filed by Chief Scientific Officer Martini Jeffrey S
- Dec 18, 2024SEC Form 4 filed by Chief Operating Officer Goin Kathleen
- Dec 18, 2024SEC Form 4 filed by CFO, Treasurer Korenberg Matthew E
- Dec 18, 2024SEC Form 4 filed by Director Jenkins George M
- Dec 18, 2024SEC Form 4 filed by President and CEO Kaupinen Wes
Quantisnow market dataNASDAQ
PIRS
Pieris Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for PIRS
Full PIRS profile on Quantisnow Follow PIRS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time